These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 20662318)

  • 41. Targeted temperature sensitive magnetic liposomes for thermo-chemotherapy.
    Pradhan P; Giri J; Rieken F; Koch C; Mykhaylyk O; Döblinger M; Banerjee R; Bahadur D; Plank C
    J Control Release; 2010 Feb; 142(1):108-21. PubMed ID: 19819275
    [TBL] [Abstract][Full Text] [Related]  

  • 42. In vitro toxicity to breast cancer cells of microsphere-delivered mitomycin C and its combination with doxorubicin.
    Cheung RY; Rauth AM; Ronaldson PT; Bendayan R; Wu XY
    Eur J Pharm Biopharm; 2006 Apr; 62(3):321-31. PubMed ID: 16330194
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Formulation and cytotoxicity of doxorubicin loaded in self-assembled bio-polyelectrolyte microshells.
    Tao X; Chen H; Sun XJ; Chen JF; Roa WH
    Int J Pharm; 2007 May; 336(2):376-81. PubMed ID: 17223293
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Simultaneous delivery of doxorubicin and GG918 (Elacridar) by new polymer-lipid hybrid nanoparticles (PLN) for enhanced treatment of multidrug-resistant breast cancer.
    Wong HL; Bendayan R; Rauth AM; Wu XY
    J Control Release; 2006 Dec; 116(3):275-84. PubMed ID: 17097178
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Recent advances in theranostic nanocarriers of doxorubicin based on iron oxide and gold nanoparticles.
    Gautier J; Allard-Vannier E; Munnier E; Soucé M; Chourpa I
    J Control Release; 2013 Jul; 169(1-2):48-61. PubMed ID: 23567046
    [TBL] [Abstract][Full Text] [Related]  

  • 46. General and cardiac toxicity of doxorubicin-loaded gelatin nanoparticles.
    Leo E; Arletti R; Forni F; Cameroni R
    Farmaco; 1997; 52(6-7):385-8. PubMed ID: 9372590
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Combined effects of laser-ICG photothermotherapy and doxorubicin chemotherapy on ovarian cancer cells.
    Tang Y; McGoron AJ
    J Photochem Photobiol B; 2009 Dec; 97(3):138-44. PubMed ID: 19811928
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Relationships between the in vitro cytotoxicity and transport characteristics of pirarubicin and doxorubicin in M5076 ovarian sarcoma cells, and comparison with those in Ehrlich ascites carcinoma cells.
    Nagai K; Nagasawa K; Sadzuka Y; Tsujimoto M; Takara K; Ohnishi N; Yokoyama T; Fujimoto S
    Cancer Chemother Pharmacol; 2002 Mar; 49(3):244-50. PubMed ID: 11935217
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Antitumor efficacy of doxorubicin released from crosslinked nanoparticulate chondroitin sulfate/chitosan polyelectrolyte complexes.
    Tsai HY; Chiu CC; Lin PC; Chen SH; Huang SJ; Wang LF
    Macromol Biosci; 2011 May; 11(5):680-8. PubMed ID: 21360679
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Preparation and characterization of modified lipid nanoparticles for doxorubicin controlled release.
    Ying XY; Du YZ; Chen WW; Yuan H; Hu FQ
    Pharmazie; 2008 Dec; 63(12):878-82. PubMed ID: 19177903
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Enhanced antitumor efficacy of clinical-grade vasculature-targeted liposomal doxorubicin.
    Pastorino F; Di Paolo D; Piccardi F; Nico B; Ribatti D; Daga A; Baio G; Neumaier CE; Brignole C; Loi M; Marimpietri D; Pagnan G; Cilli M; Lepekhin EA; Garde SV; Longhi R; Corti A; Allen TM; Wu JJ; Ponzoni M
    Clin Cancer Res; 2008 Nov; 14(22):7320-9. PubMed ID: 19010847
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Surfactant-polymer nanoparticles overcome P-glycoprotein-mediated drug efflux.
    Chavanpatil MD; Khdair A; Gerard B; Bachmeier C; Miller DW; Shekhar MP; Panyam J
    Mol Pharm; 2007; 4(5):730-8. PubMed ID: 17705442
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Dual-functional alginic acid hybrid nanospheres for cell imaging and drug delivery.
    Guo R; Li R; Li X; Zhang L; Jiang X; Liu B
    Small; 2009 Mar; 5(6):709-17. PubMed ID: 19235799
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Tumoral acidic extracellular pH targeting of pH-responsive MPEG-poly(beta-amino ester) block copolymer micelles for cancer therapy.
    Ko J; Park K; Kim YS; Kim MS; Han JK; Kim K; Park RW; Kim IS; Song HK; Lee DS; Kwon IC
    J Control Release; 2007 Nov; 123(2):109-15. PubMed ID: 17894942
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Heparin-deoxycholic acid chemical conjugate as an anticancer drug carrier and its antitumor activity.
    Park K; Lee GY; Kim YS; Yu M; Park RW; Kim IS; Kim SY; Byun Y
    J Control Release; 2006 Sep; 114(3):300-6. PubMed ID: 16884806
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Biocompatible graphene oxide nanoparticle-based drug delivery platform for tumor microenvironment-responsive triggered release of doxorubicin.
    Zhao X; Liu L; Li X; Zeng J; Jia X; Liu P
    Langmuir; 2014 Sep; 30(34):10419-29. PubMed ID: 25109617
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Comparative cytotoxicity of gold-doxorubicin and InP-doxorubicin conjugates.
    Zhang X; Chibli H; Kong D; Nadeau J
    Nanotechnology; 2012 Jul; 23(27):275103. PubMed ID: 22710097
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Novel hyaluronic acid (HA) coated drug carriers (HCDCs) for human breast cancer treatment.
    Hyung W; Ko H; Park J; Lim E; Park SB; Park YJ; Yoon HG; Suh JS; Haam S; Huh YM
    Biotechnol Bioeng; 2008 Feb; 99(2):442-54. PubMed ID: 17625788
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Incorporation and in vitro release of doxorubicin in thermally sensitive micelles made from poly(N-isopropylacrylamide-co-N,N-dimethylacrylamide)-b-poly(D,L-lactide-co-glycolide) with varying compositions.
    Liu SQ; Tong YW; Yang YY
    Biomaterials; 2005 Aug; 26(24):5064-74. PubMed ID: 15769542
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Targeted magnetic liposomes loaded with doxorubicin.
    Pradhan P; Banerjee R; Bahadur D; Koch C; Mykhaylyk O; Plank C
    Methods Mol Biol; 2010; 605():279-93. PubMed ID: 20072888
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.